본문 바로가기
KERD
논문KCI 등재

Clinical Validation of the Psychotic Depression Assessment Scale, Hamilton Depression Rating Scale-6, and Brief Psychiatric Rating Scale-5: Results from the Clinical Research Center for Depression Study

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류정신과학

초록

Objective: The aim of this study was to validate the psychotic depression assessment scale (PDAS), which includes the six-item melancholia subscale from the Hamilton depression rating scale (HAMD-6) and the five-item psychosis subscale from the brief psychiatric rating scale (BPRS-5). Data from the Clinical Research Center for Depression (CRESCEND) study, which is a 52-week naturalistic trial, were analyzed. Methods: Fifty-two patients with psychotic depression from the CRESCEND study met our inclusion criteria. The patients underwent the following psychometric assessments: the PDAS, including HAMD-6 and BPRS-5, the clinical global impression scales, the HAMD, the positive symptom subscale, and the negative symptom subscale. Assessments were performed at the baseline and then at weeks 1, 2, 4, 8, 12, 24, and 52. Spearman correlation analyses were used to assess the clinical validity and responsiveness of the PDAS. Results: The clinical validity and responsiveness of the PDAS, including HAMD-6 and BPRS-5, were acceptable, with the exception of the clinical responsiveness of the PDAS for positive symptoms and the clinical responsiveness of BPRS-5 for negative symptoms. Conclusion: The clinical relevance of the PDAS has been confirmed and this clinical validation will enhance its clinical utility and availability.

Abstract

Objective: The aim of this study was to validate the psychotic depression assessment scale (PDAS), which includes the six-item melancholia subscale from the Hamilton depression rating scale (HAMD-6) and the five-item psychosis subscale from the brief psychiatric rating scale (BPRS-5). Data from the Clinical Research Center for Depression (CRESCEND) study, which is a 52-week naturalistic trial, were analyzed. Methods: Fifty-two patients with psychotic depression from the CRESCEND study met our inclusion criteria. The patients underwent the following psychometric assessments: the PDAS, including HAMD-6 and BPRS-5, the clinical global impression scales, the HAMD, the positive symptom subscale, and the negative symptom subscale. Assessments were performed at the baseline and then at weeks 1, 2, 4, 8, 12, 24, and 52. Spearman correlation analyses were used to assess the clinical validity and responsiveness of the PDAS. Results: The clinical validity and responsiveness of the PDAS, including HAMD-6 and BPRS-5, were acceptable, with the exception of the clinical responsiveness of the PDAS for positive symptoms and the clinical responsiveness of BPRS-5 for negative symptoms. Conclusion: The clinical relevance of the PDAS has been confirmed and this clinical validation will enhance its clinical utility and availability.

참고문헌 (45)

  1. Østergaard SD, "Considerations on the ICD-11 classification of psychotic depression", Psychother Psychosom, 81, pp.135~144 (2012)
  2. Østergaard SD, "Persistent delusional theme over 13 episodes of psychotic depression", Acta Neuropsychiatr, 25, pp.370~373 (2013)
  3. Østergaard SD, "Risk factors for conversion from unipolar psychotic depression to bipolar disorder", Bipolar Disord, 16, pp.180~189 (2014)
  4. Østergaard SD, "Environmental and familial risk factors for psychotic and non-psychotic severe depression", J Affect Disord, 147, pp.232~240 (2013)
  5. Vythilingam M, "Psychotic depression and mortality", Am J Psychiatry, 160, pp.574~576 (2003)
  6. Coryell W, "Importance of psychotic features to longterm course in major depressive disorder", Am J Psychiatry, 152, pp.483~489 (1996)
  7. Zalpuri I, "Does psychosis increase the risk of suicide in patients with major depression? : A systemic review", J Affect Disord, 198, pp.23~31 (2016)
  8. Zaninotto L, "Cognitive markers of psychotic unipolar depression : a meta-analytic study", J Affect Disord, 174, pp.580~585 (2015)
  9. Østergaard SD, "The association between physical morbidity and subtypes of severe depression", Psychother Psychosom, 82, pp.45~52 (2013)
  10. Nelson JC, "DST studies in DST studies in psychotic depression : a meta-analysis", Am J Psychiatry, 154, pp.1497~1503 (1997)
  11. Posener JA, "24-hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression", Arch Gen Psychiatry, 57, pp.755~760 (2000)
  12. Bijanki KR, "Hippocampal and left subcallosal anterior cingulate atrophy in psychotic depression", PLoS One, 9, pp.e110770~ (2014)
  13. Meltzer HY, "Serum dopamine-beta-hydroxylase activity in affective psychoses and schizophrenia. Decreased activity in activity in unipolar psychotically depressed patients", Arch Gen Psychiatry, 33, pp.585~591 (1976)
  14. Meyers BS, "Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression", Biol Psychiatry, 45, pp.448~452 (1999)
  15. Lichtenberg P, "Subtyping major depressive disorder", Psychother Psychosom, 79, pp.131~135 (2010)
  16. Schatzberg AF, "Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?", Am J Psychiatry, 149, pp.733~745 (1992)
  17. Østergaard SD, "The validity of the severity-psychosis hypothesis in depression", J Affect Disord, 140, pp.48~56 (2012)
  18. Østergaard SD, "The association between psychotic mania, psychotic depression and mixed affective episodes among 14,529 patients with bipolar disorder", J Affect Disord, 147, pp.44~50 (2013)
  19. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders", American Psychiatric Association, ~ (2013)
  20. Østergaard SD, "Measuring psychotic depression", Acta Psychiatr Scand, 129, pp.211~220 (2014)
  21. Østergaard SD, "Measuring treatment response in psychotic depression : the psychotic depression assessment scale(PDAS)takes both depressive and psychotic symptoms into account", J Affect Disord, 160, pp.68~73 (2014)
  22. Østergaard SD, "Rating scales measuring the severity of psychotic depression", Acta Psychiatr Scand, 132, pp.335~344 (2015)
  23. Hamilton M, "A rating scale for depression", J Neurol Neurosurg Psychiatry, 23, pp.56~62 (1960)
  24. Overall JE, "The brief psychiatric rating scale", Psychol Rep, 10, pp.779~812 (1962)
  25. Østergaard SD, "Establishing the cut-off for remission and severity-ranges on the psychotic depression assessment scale(PDAS)", J Affect Disord, 190, pp.111~114 (2016)
  26. Park SC, "Is the psychotic depression assessment scale a useful diagnostic tool? : the CRESCEND study", J Affect Disord, 166, pp.79~85 (2014)
  27. Park SC, "Is the BPRS-5 subscale of the psychotic depression assessment scale a reliable screening tool for psychotic depression? : Results from the CRESCEND study", J Affect Disord, 174, pp.188~191 (2015)
  28. 박선철, "Gender Differences in the Clinical Characteristics of Psychotic Depression: Results from the CRESCEND Study", Clinical Psychopharmacology and Neuroscience, 13(3), pp.256~262 (2015), 대한정신약물학회
  29. 박선철, "Distinctive Clinical Correlates of Psychotic Major Depression: The CRESCEND Study", PSYCHIATRY INVESTIGATION, 11(3), pp.281~289 (2014), 대한신경정신의학회[DOI]
  30. Seo HJ, "Age-related differences in suicidality between young people and older adults with depression : data from a nationwide depression cohort study in Korea(the CRESCEND study)", Compr Psychiatry, 56, pp.85~92 (2015)
  31. 배경열, "Antidepressant Prescribing Patterns in Korea: Results from the Clinical Research Center for Depression Study", PSYCHIATRY INVESTIGATION, 8(3), pp.234~244 (2011), 대한신경정신의학회
  32. Hong Jin Jeon, "Review of Cohort Studies for Mood Disorders", PSYCHIATRY INVESTIGATION, 13(3), pp.265~276 (2016), 대한신경정신의학회[DOI]
  33. Guy W, "Early Clinical Drug Evaluation Unit (ECDEU) Assessment Manual for Psychopharmacology", US Department of Health, Education, and Welfare Publication, National Institute of Mental Health, ~ (1976)
  34. Lachar D, "New subscales for an anchored version of the Brief Psychiatric Rating Scale: construction, reliability, and validity in acute psychiatric admissions", Psychol Assess, 13, pp.384~395 (2001)
  35. Keller J, "Current issues in the classification of psychotic major depression", Schizophr Bull, 33, pp.877~885 (2007)
  36. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders", American Psychiatric Association, ~ (1994)
  37. First MB, "Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition", Biometrics Research Department, New York State Psychiatric Institute, ~ (1995)
  38. Østergaard SD, "Clinical and psychometric validation of the psychotic depression assessment scale", J Affect Disord, 173, pp.261~268 (2015)
  39. 이중서, "한국판 Hamilton 우울증 평가 척도의 신뢰도, 타당도 연구", 신경정신의학, 44(4), pp.456~465 (2005), 대한신경정신의학회
  40. 이중서, "한국판 양성 및 음성증후군 척도(Positive and Negative Syndrome Scale)의 신뢰도와 타당도", 신경정신의학, 40(6), pp.1090~1105 (2001), 대한신경정신의학회
  41. Roval AP, "Social Science Research Design and Statistics: A Practitioner’s Guide to Research Methods and IBM SPSS", pp.375~ (2013), Watertree Press
  42. Deligiannidis KM, "A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures", J Clin Psychiatry, 74, pp.1003~1009 (2013)
  43. Gournellis R, "Clinical correlates of age of onset in psychotic depression", Arch Gerontol Geriatr, 52, pp.94~98 (2011)
  44. Cassano P, "Differential impact of isolated psychotic symptoms on treatment outcome of major depressive disorder in the STAR*D cohort of Whites, Blacks and Latinos", J Affect Disord, 150, pp.578~584 (2013)
  45. Gerretsen P, "Impaired insight into delusions predicts treatment outcome during a randomized controlled trial for psychotic depression(STOP-PD study)", J Clin Psychiatry, 76, pp.427~433 (2015)

관련 논문AI추천

Gender Differences in the Clinical Characteristics of Psychotic Depression: Results from the CRESCEND Study김재민, 김정범, 박선철, 박용천, 이민수, 임현우, 전태연, Søren Dinesen Østergaard대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2015 · 제13권 제3호The Symptom Frequency Characteristics of the Hamilton Depression Rating Scale and Possible Symptom Clusters of Depressive Disorders in Korea: The CRESCEND Study김재민, 이민수, 전태연, Jung Bum Kim, Sae-Heon Jang, Seung Hee Jeong, Young-Myo Jae, Young-Nam Park대한신경정신의학회 · PSYCHIATRY INVESTIGATION2011 · 제8권 제4호한국어판 정신분열병의 캘거리 우울증 척도의 신뢰도 및 타당도 연구김용구, 원성두, 이경민, 이분희, 장홍석, 최현석, 한창수대한신경정신의학회 · 신경정신의학2005 · 제44권 제4호Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar SampleAlessandro Serretti, Daniel Souery, Diana De Ronchi, Giovanni Camardese, Joseph Zohar, Julien Mendlewicz, Leonardo Zaninotto, Luigi Janiri, Raffaella Calati, Siegfried Kasper, Stuart Montgomery대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2015 · 제13권 제1호Development of a Korean Version of the Perceived Deficits Questionnaire-Depression for Patients with Major Depressive Disorder강희주, 김상대, 김재민, 이용성, 홍진표대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2016 · 제14권 제1호Characteristics of Residual Symptoms in Korean Patients with Major Depressive Disorder: A Validation Study for the Korean Version of Depression Residual Symptom Scale고영훈, 신철민, Ho-Kyoung Yoon, Sang Won Jeon, Seo Young Yoon, Sol A Park대한신경정신의학회 · PSYCHIATRY INVESTIGATION2018 · 제15권 제2호

이 간행물의 다른 논문 (21건)